The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
As discussed in last week’s Regs & Eggs blog post, the US Department of Health and Human Services (HHS) recently released additional budget documents to support the department’s fiscal year (FY) 2026 ...
As our population continues to age, Medicare’s role in the American health care system continues to grow. And Medicare’s power goes beyond health care; it was the power of the Medicare program that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results